Scilex Holding (SCLX) Capital Expenditures (2022 - 2026)
Scilex Holding (SCLX) posted Capital Expenditures of $389000.0 for Q2 2026, down 35.7% on a QoQ basis from $605000.0 in Q1 2026.
Analysis
Scilex Holding (SCLX) Capital Expenditures (2022 - 2026) Analysis & Trends
Scilex Holding has reported Capital Expenditures for 5 years, with the latest figure at $389000.0 in Q2 2026.
- On a quarterly basis, Capital Expenditures changed N/A year-over-year to $389000.0 in Q2 2026; TTM through Jun 2026 was $1.1 million, a N/A change from a year earlier, with the FY2025 full-year figure at $133000.0, up 343.33% from the prior year.
- Capital Expenditures was $389000.0 for Q2 2026 at Scilex Holding, down from $605000.0 in the prior quarter.
- The five-year high for Capital Expenditures was $605000.0 in Q1 2026, with the low at -$997000.0 in Q1 2023.
- Average Capital Expenditures over 5 years is $4222.2, with a median of $35000.0 recorded in 2022.
- The sharpest annual moves came in 2023 and 2024: Capital Expenditures slumped 245.71% in 2023, then surged 103.01% in 2024.
- Over 5 years, Capital Expenditures stood at $35000.0 in 2022, then plunged by 245.71% to -$51000.0 in 2023, then soared by 158.82% to $30000.0 in 2024, then jumped by 343.33% to $133000.0 in 2025, then jumped by 192.48% to $389000.0 in 2026.
- The last three Capital Expenditures figures came in at $389000.0 (Q2 2026), $605000.0 (Q1 2026), and $133000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | 533.00 Mn |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | 2.29 Mn |
| 8 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | 12.41 Mn |
| 9 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn | 108.00 Mn |
| 10 | Scilex Holding | 38.06 Mn | -76.90 Mn | 3.97 Mn | 389,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 389,000.00 |
| Mar 31, 2026 | 605,000.00 |
| Dec 31, 2025 | 133,000.00 |
| Mar 31, 2024 | 30,000.00 |
| Dec 31, 2023 | -51,000.00 |
| Jun 30, 2023 | 193,000.00 |
| Mar 31, 2023 | -997,000.00 |
| Dec 31, 2022 | 35,000.00 |
| Sep 30, 2022 | -299,000.00 |